IntraHealth International is thrilled to welcome Christopher Constantian as our new chief growth officer, starting November 9, 2020.

As part of the executive team at IntraHealth, Constantian will lead the Center for Strategy & Development, including all new business development. He and his team will form partnerships that expand IntraHealth's support to frontline health workers and strengthen health systems around the world.

“We’re so excited to be welcoming Chris to IntraHealth in this new role,” says Polly Dunford, IntraHealth’s president and CEO. “These are challenging times for health workers everywhere. Last year, our programs reached 364,184 health workers, but we want to reach even more—now and after the pandemic. Chris’s role will be crucial as we expand our impact and address these big, next-generation challenges in global health."

Before joining IntraHealth, Constantian served in senior positions at Chemonics International, including as managing director of its global health division. He’s also held senior business development roles at Management Sciences for Health, Perkins School for the Blind, and Tetra Tech.

“IntraHealth is a great organization doing such important work,” Constantian says. “There has never been a more critical time to support frontline health workers. As I watched 2020 unfold, I felt like I wanted to personally do more to help, so I am thrilled to get to contribute directly to IntraHealth’s mission and help it reach even more communities worldwide.”

Learn more about Chris Constantian.